DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews
AstraZeneca (LON:AZN) and MSD Inc., Kenilworth, N.J., US (known as Merck & Co., Inc. inside the US and Canada) today announced that a supplemental New Drug Application for Lynparza has been accepted and ...
Read Article »FTSE 100
-
Rio Tinto further strengthens its pipeline of opportunities
-
Experian Another quarter of good growth
-
Sage Group Soni Jiandani to step down as Non-Executive Director
-
Scottish Mortgage Investment Trust PLC raises further borrowings of £188 million
-
Pearson Sally Johnson to succeed Coram Williams as CFO
-
Persimmon continues to make good progress
-
SSE to complete sale of SSE Energy Services Group to OVO Energy
-
WPP to hold briefing for investors and analysts today
-
Persimmon Non-Executive Director Claire Thomas to step down
-
BHP Group provide Board update
-
Taylor Wimpey Results will be in line with expectations
-
AstraZeneca to close Phase III STRENGTH trial for Epanova
-
Standard Chartered announce end of Independent Consultant term
-
AstraZeneca's Lynparza granted FDA Priority Review for PAOLA-1
-
Mondi CEO Peter Oswald to step down
-
JD Sports Fashion Positive like for like trends
-
Bunzl acquires a further business in the US
-
Tesco deliver fifth consecutive Christmas of growth
-
J Sainsbury Strong grocery performance and online growth
-
Anglo American responds to statement from Sirius Minerals
-
Morrisons Execution strong and profitability robust
-
AstraZeneca's Lokelma approved in China
-
Prudential Vietnam establish exclusive bancassurance partnership with SeABank
-
Compass Group Paul Walsh to step down as Chairman and Director
-
AstraZeneca's Farxiga granted FDA Priority Review
-
NMC Health announce Independent Review Oversight Committee
-
British American Tobacco PLC Provide Response to FDA Flavour Guidance
-
Next plc Announce Q4 Sales up 5.2%, ahead of forecast
-
AstraZeneca announce FDA approval of Enhertu in the US
-
BHP Group Andrew Mackenzie to retire 31 March 2020
-
AstraZeneca's triple-combination therapy approved in China for patients with COPD
-
NMC Health announces Independent Review
-
Anglo American receives operating licence for Minas-Rio tailings facility
-
GSK's ViiV Healthcare receives complete response letter from FDA for cabotegravir and rilpivirine
-
AstraZeneca sells commercial rights to Arimidex and Casodex
-
Royal Dutch Shell release 2019 Q4 update note
-
Royal Bank of Scotland announce changes to NWM Executive Management team
-
NMC Health responds to share price movement
-
Ferguson appoint Simon Oakland as interim CEO at Wolseley UK
-
Pearson to sell remaining 25% stake in Penguin Random House to Bertelsmann